CClinicalTrials.gg
CompletedNCT03337802PREMEDIUpdated Jun 8, 2022

Effect of Mediterranean Diet During Pregnancy on the Onset of Overweight and Obesity in the Offspring

An interventional study of mediterranean diet in Food Allergy, sponsored by Federico II University. Completed at 1 site in Italy. Open to female participants aged 20 Years to 35 Years. Per ClinicalTrials.gov, last updated 2022-06-08.

Sponsored by Federico II University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
20 Years to 35 Years
Sex
Female
01

Study summary

The first 1,000 days of life, from the conception to 24 months, are crucial to achieve long-term health outcomes and represent a strategic period to intervene under prevention and public health perspective. Nutritional exposures during this critical period of life can influence the future disease susceptibility. Maternal diet during pregnancy has been linked to offspring overweight/obesity risk and it could represent a potential target for overweight/obesity prevention. The Mediterranean Diet (MD) is considered one of the healthiest dietary models, which impacts beneficially the gut microbiome (GM), providing high amounts of fiber, antioxidants polyphenols and vitamins, and a balanced ratio of essential fatty acids (ω6:ω3). Notably, the MD beneficial effects are due to the synergistic and interactive combinations of nutrients, and the modulation of gene expression through epigenetic changes. Unofrtunately, the MD mechanisms during pregnancy in the prevention of childhood overweight/obesity are not yet fully known.

Read the detailed description

The PREMEDI study has been designed to evaluate the effects of Mediterranean Diet during pregnancy on the occurrence of overweight/obesity at 24 months in the offspring.

02

Conditions studied

  • Food Allergy
03

Who can participate

Ages eligible
20 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • women
  • caucasian ethnicity
  • aged between 20 and 35 years

Exclusion criteria

Exclusion Criteria:

  • proven presence of infections during pregnancy and at delivery,
  • twin pregnancy,
  • ongoing malignancies,
  • major gastrointestinal tract malformations,
  • immunodeficiencies,
  • diabetes and other chronic diseases at each organ or apparatus level,
  • chronic intestinal inflammatory diseases,
  • gastrointestinal function disorders,
  • celiac disease;
  • history of abdominal surgery with intestinal resection,
  • neuropsychiatric disorders,
  • central nervous system disorders,
  • vegan diet.
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • No intervention
    Pregnant women at standard diet

    obstetrical and gynecological follow-up

  • Experimental
    Pregnant women at mediterranean diet

    obstetrical and gynecological follow-up + nutritional counseling

    Behavioral: mediterranean diet

Interventions

  • Behavioralmediterranean diet

    The Mediterranean diet (MD) is highly regarded as a healthy balanced diet. It is distinguished by a beneficial fatty acid profile that is rich in both monounsaturated and polyunsaturated fatty acids, high levels of polyphenols and other antioxidants, high intake of fiber and other low glycemic carbohydrates, and relatively greater vegetable than animal protein intake. Specifically, olive oil, assorted fruits, vegetables, cereals, legumes, and nuts; moderate consumption of fish, poultry, and red wine; and a lower intake of dairy products, red meat, processed meat and sweets characterize the traditional MD.

05

What researchers measure

Primary outcomes

  1. The effects of Mediterranean Diet in pregnancy on the occurrence of overweight/obesity at 24 months in the offspring

    The children body growth indices are evaluated at 24 months

    Time frame: After 24 months from the delivery

Secondary outcomes

  1. The effect of Mediterranean Diet pregnancy on the composition of maternal gut microbiota through analysis of gut microbiota composition.

    Fecal bacteria DNA will be extracted using standard technique outlined by the Earth Microbiome Project. 16S V4-region amplicon libraries will be produced using previously described primers and sequenced using the IlluminaMiSeqplatform (150bpx2). Bacterial load will be determined by qPCR using a standard curve derived from a plasmid containing a single copy of the 16S rRNAencoding gene. Sequence data has been deposited in MG RAST under accession numbers 4571868.3-4571924.3 and project number 10023. Paired end reads will be quality trimmed and processed for OTU (operational taxonomic unit) clustering using UPARSE pipeline, set at 0.97% identity cutoff. Taxonomic status will be assigned to the high quality (\<1% incorrect bases) candidate OTUs using the "parallel_assign_taxonomy_rdp.py" script of QIIME software. Multiple sequence alignment and phylogenetic reconstruction will be performed using PyNast and FastTree.

    Time frame: after 9 months (at the end of the pregnancy)

  2. The effect of Mediterranean diet in pregnancy on the production of short chain fatty acids (butyrate and propionate) in the intestinal tract.

    Fecal SCFAs concentration Frozen feces weighing 1g will be diluted with saline solution, vortexed, and centrifuged. Supernatants will be filtered and stored at -20°C until analysis. Frozen fecal extracts will be acidified and extracted in duplicate. A quantity of the pooled extract containing acidified butyrate, propionate or acetate will be transferred into a 2ml glass vial and loaded onto an Agilent Technologies 7890 gas chromatograph (GC) system. Detection will be achieved using a flame ionization detector. Peaks will be identified using a mixed external standard and quantified by peak height/internal standard ratio. To examine whether fecal butyrate levels correlates with bacterial diversity (Shannon diversity index) and evenness (Pielou's evenness index) and abundance patterns across multiple groups we will calculate the Spearman correlation using the cor.test function implemented in R (http://www.r-project.org/

    Time frame: after 9 months (at the end of the pregnancy)

  3. The adherence to Mediterranean Diet in the enrolled women

    Women Mediterranean Diet adherence score is evaluated through the "Med Diet Score"

    Time frame: from 0 to 9 months (at the end of pregnancy)

  4. The effect of dietary counseling on dietary habits

    The diet composition in macro- and micronutrients is evaluated

    Time frame: from 0 to 9 months (at the end of pregnancy)

  5. The effect of Mediterranean diet in pregnancy on the maternal weight gain and complications

    To evaluate the effect of Mediterranean diet in pregnancy on the maternal weight gain and complications (gestational hypertension, infections, gestational diabetes, preeclampsia, use of cesarean)

    Time frame: from 0 to 9 months (at the end of pregnancy)

  6. The effect of Mediterranean diet in pregnancy on perinatal and fetal complications

    Perinatal and fetal complications occurrence are evaluated

    Time frame: from 0 to 9 months (at the end of pregnancy)

  7. The effect of Mediterranean Diet in pregnancy on the duration of breastfeeding and the composition of breast milk

    The effect of Mediterranean Diet in pregnancy on the duration of breastfeeding and the composition of breast milk (short chain fatty acids, bacterial DNA, adipocytokines.

    Time frame: from 0 to 4 months lactation

  8. The effect of Mediterranean Diet on the occurrence of allergies and use of antibiotics in the first 2 years of life.

    The occurrence of allergies and the use of antibiotics in the first 2 years of life are evaluated

    Time frame: Every 6 months from offspring birth to 2 years

  9. The effect of Mediterranean Diet on the epigenetic modulation of genes involved in the regulation of immune system and metabolic pathways in the offspring

    The evaluation of the effect of Mediterranean Diet during pregnancy on the epigenetic modulation of genes involved in the immune system and metabolic pathways in the offspring through the cord blood epigenome-wide association study

    Time frame: At delivery

06

Study locations

1 site
  • University of Naples Federico II
    Naples, 80131, Italy
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03337802
Lead sponsor
Federico II University
Responsible party
Roberto Berni Canani, MD, PhD (MD, PhD, Federico II University) — Principal investigator
First posted
Nov 9, 2017
Start date
Nov 30, 2017
Primary completion
Nov 30, 2020
Completion
Jan 31, 2021
Last update
Jun 8, 2022

Study contacts

Roberto Berni Canani
principal investigator · Department of Traslational Medical Science, University of Naples Federico II

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion